Galectin Therapeutics Inc (GALT)

Galectin Therapeutics Inc (GALT) 最新ニュース

Wall Street Breakfast: The Week Ahead

Seeking Alpha

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

The Motley Fool

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

GlobeNewswire Inc.